Literature DB >> 35816219

Functional roles of E3 ubiquitin ligases in prostate cancer.

Yiting Zhao1,2,3, Jinyun Li1,2, Jun Chen3, Meng Ye1,2, Xiaofeng Jin4,5.   

Abstract

Prostate cancer (PCa) is a malignant epithelial tumor of the prostate gland with a high male cancer incidence. Numerous studies indicate that abnormal function of ubiquitin-proteasome system (UPS) is associated with the progression and metastasis of PCa. E3 ubiquitin ligases, key components of UPS, determine the specificity of substrates, and substantial advances of E3 ubiquitin ligases have been reached recently. Herein, we introduce the structures and functions of E3 ubiquitin ligases and summarize the mechanisms of E3 ubiquitin ligases-related PCa signaling pathways. In addition, some progresses in the development of inhibitors targeting E3 ubiquitin ligases are also included.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Castration-resistant prostate cancer (CRPC); E3 ubiquitin ligases; Prostate cancer (PCa); Signaling pathways; Targeted therapy

Mesh:

Substances:

Year:  2022        PMID: 35816219     DOI: 10.1007/s00109-022-02229-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  156 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Protein Degradation and the Pathologic Basis of Disease.

Authors:  John Hanna; Angel Guerra-Moreno; Jessie Ang; Yagmur Micoogullari
Journal:  Am J Pathol       Date:  2018-10-10       Impact factor: 4.307

3.  Cancer treatment and survivorship statistics, 2019.

Authors:  Kimberly D Miller; Leticia Nogueira; Angela B Mariotto; Julia H Rowland; K Robin Yabroff; Catherine M Alfano; Ahmedin Jemal; Joan L Kramer; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-06-11       Impact factor: 508.702

4.  Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation.

Authors:  Fu Shang; Gejing Deng; Qing Liu; Weimin Guo; Arthur L Haas; Bernat Crosas; Daniel Finley; Allen Taylor
Journal:  J Biol Chem       Date:  2005-03-24       Impact factor: 5.157

Review 5.  Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.

Authors:  Aaron Ciechanover
Journal:  Best Pract Res Clin Haematol       Date:  2017-09-22       Impact factor: 3.020

6.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.

Authors:  Philip Cornford; Joaquim Bellmunt; Michel Bolla; Erik Briers; Maria De Santis; Tobias Gross; Ann M Henry; Steven Joniau; Thomas B Lam; Malcolm D Mason; Henk G van der Poel; Theo H van der Kwast; Olivier Rouvière; Thomas Wiegel; Nicolas Mottet
Journal:  Eur Urol       Date:  2016-08-31       Impact factor: 20.096

Review 7.  E3 ubiquitin ligases in cancer and implications for therapies.

Authors:  Dong Wang; Leina Ma; Bin Wang; Jia Liu; Wenyi Wei
Journal:  Cancer Metastasis Rev       Date:  2017-12       Impact factor: 9.264

Review 8.  Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.

Authors:  Keiichiro Mori; Noriyoshi Miura; Hadi Mostafaei; Fahad Quhal; Reza Sari Motlagh; Benjamin Pradere; Shoji Kimura; Takahiro Kimura; Shin Egawa; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-03-09       Impact factor: 5.554

Review 9.  Current treatment strategies for advanced prostate cancer.

Authors:  Kazumasa Komura; Christopher J Sweeney; Teruo Inamoto; Naokazu Ibuki; Haruhito Azuma; Philip W Kantoff
Journal:  Int J Urol       Date:  2017-12-20       Impact factor: 3.369

Review 10.  Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways.

Authors:  Brenda A Schulman; J Wade Harper
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-08       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.